Xr Securities LLC Novavax Inc Transaction History

Xr Securities LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 14, 2022	SELL	$69.73 - $142.9 $292,796 - $600,037	-4,199 Closed	0 $0
Q4 2021 Jan 10, 2022	BUY	$134.56 - $217.97 $247,052 - $400,192	1,836 Added 77.7%	4,199 $601,000
Q1 2021 Apr 29, 2021	SELL	$112.98 - $319.93 $109,138 - $309,052	-966 Reduced 29.02%	2,363 $428,000
Q4 2020 Jan 13, 2021	SELL	$78.74 - $139.5 $29,133 - $51,615	-370 Reduced 10.0%	3,329 $371,000
Q3 2020 Oct 28, 2020	BUY	$79.44 - $178.51 $293,848 - $660,308	3,699 New	3,699 $401,000

286

84.7M

5.38M

8.62M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $718M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Xr Securities LLC, based on Form 13F filings with the SEC.

Stay updated on Xr Securities LLC with notifications on news.